Published in AIDS Weekly, December 15th, 2003
Revenues for the quarter totaled $897,000, versus revenues of $493,000 for the comparable period in 2002 and $749,000 for the previous quarter ended June 30, 2003. The net loss attributable to common stockholders for the quarter was $7.3 million, or $0.11 per common share, compared to a net loss of $1.5 million, or $0.51 per common share for the 3 months ended September 30, 2002.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.